EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Molecular Classification of Endometrial Cancers Using an Integrative DNA Sequencing Panel

Soyoun R Kim, Leslie Oldfield, Raymond H Kim, Osvaldo Espin-Garcia, Kathy Han, Danielle Vicus, Lua Eiriksson, Alicia Tone, Aaron Pollett, Matthew Cesari, Blaise Clarke, Marcus Q Bernardini und 2 weitere

Journal of Surgical Oncology · 2025

DOI: 10.1002/jso.27973 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von Soyoun R Kim und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gynecologic Oncology, Princess Margaret Cancer Centre, Sinai Health Systems, University Health Network, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Sequence Analysis, DNA, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: This study was supported by funding from the Hold'em for Life Clinician Scientist Award and Violet River Award in Gynecology from the Department of Obstetrics….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Adoption of molecular classification in endometrial cancer (EC) into clinical practice remains challenging due to complexity in coordination of multiple assays. We aimed to develop a simple molecular technique to classify ECs into four subgroups using our custom‐designed targeted sequencing panel.

Methods

Patients with newly diagnosed ECs were prospectively recruited from three cancer centres in Ontario, Canada. Using our panel, 181 ECs were sequenced. Variants were analysed for pathogenicity and clinicopathologic information was collected through medical records retrospectively.

Results

Of 181, 86 (48%) were mismatch repair deficient (MMRd), of which 62 (72%) harboured MLH1 promoter methylation and 24 (28%) had pathogenic variants in MMR genes. Of single classifiers, three (1.8%) had pathogenic POLE ( POLE mut), 15 (9%) had TP53 mutations (p53abn) and 61 (37%) had no specific molecular profile subtype (NSMP). Sixteen (9%) had more than one molecular classifying feature, with eight (4%) MMRd‐p53abn, six (3%) POLE mut‐MMRd, one (0.5%) POLE mut‐MMRd‐p53abn and one (0.5%) POLE mut‐p53abn. When MMRd group was further subclassified according to mechanism of MMR loss, MLH1 promoter methylated group had worse outcomes than those with somatic MMR pathogenic variants.

Conclusions

Our panel can classify ECs into four subgroups through a simplified process and can be implemented reflexively in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsSequence Analysis, DNABiomarkers, TumorHumansFemaleMiddle AgedAgedDNA Mismatch RepairMutationMutL Protein Homolog 1DNA MethylationProspective StudiesRetrospective StudiesAged, 80 and overAdultTumor Suppressor Protein p53Promoter Regions, Genetic

Stichwörter der Autor:innen

endometrial cancermolecular classificationmolecular subtypenext‐generation sequencingpanel

Substanzen

MutL Protein Homolog 1MLH1 protein, humanBiomarkers, TumorTumor Suppressor Protein p53TP53 protein, human

Autor:innen und Institutionen

  • Division of Gynecologic Oncology, Princess Margaret Cancer Centre, Sinai Health Systems, University Health Network, Toronto, Ontario, Canada.
  • Department of Obstetrics and Gynaecology, University of Toronto, Toronto, Ontario, Canada.
  • Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Fred A Litwin Family Centre for Genetic Medicine, University Health Network, Toronto, Ontario, Canada.
  • Zane Cohen Centre for Digestive Diseases, Familial Gastrointestinal Cancer Registry, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Sinai Health Systems, University Health Network, Toronto, Ontario, Canada.

Förderung

  • This study was supported by funding from the Hold'em for Life Clinician Scientist Award and Violet River Award in Gynecology from the Department of Obstetrics…

Zitieren

APA

Kim, S. R., Oldfield, L., Kim, R. H., Espin-Garcia, O., Han, K., Vicus, D., Eiriksson, L., Tone, A., Pollett, A., Cesari, M., Clarke, B., Bernardini, M. Q., Pugh, T. J., & Ferguson, S. E. (2025). Molecular Classification of Endometrial Cancers Using an Integrative DNA Sequencing Panel. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27973

Vancouver

Kim SR, Oldfield L, Kim RH, Espin-Garcia O, Han K, Vicus D, et al. Molecular Classification of Endometrial Cancers Using an Integrative DNA Sequencing Panel. Journal of Surgical Oncology. 2025. doi:10.1002/jso.27973

BibTeX
@article{Kim2025,
  author = {Kim, Soyoun R and Oldfield, Leslie and Kim, Raymond H and Espin-Garcia, Osvaldo and Han, Kathy and Vicus, Danielle and Eiriksson, Lua and Tone, Alicia and Pollett, Aaron and Cesari, Matthew and Clarke, Blaise and Bernardini, Marcus Q and Pugh, Trevor J and Ferguson, Sarah E},
  title = {Molecular Classification of Endometrial Cancers Using an Integrative DNA Sequencing Panel},
  journal = {Journal of Surgical Oncology},
  year = {2025},
  doi = {10.1002/jso.27973}
}
Kostenlos starten →